Figure 2From: Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study GroupEffect of various factors on overall survival (OS). (a) Effect of Age on OS. (b) Effect of bone marrow blast percentage on OS. (c) Effect of achievement of any type of hematologic response on OS. (d) Effect of deepening of response after first response on OS. Patients experiencing a further deepening of response after first response had significantly longer overall survival, than those patients for whom first response was best response.Back to article page